ARCHIVES

FDA Plans Greater Disclosures Over Wide Range Of Activities

This article is from The Cancer Letter archive.

Vol. 36 No. 19 | May 21, 2010

Download PDF Visit The Full Archive

Related Articles

ACS Says 41 Percent Survive 5 Years

January 2, 1981

Guest Editorial: A Near-Term Solution: NCI And COG Agree on Plan to Maintain Enrollment

May 23, 2014

Panel Calls For New Office, Advisory Groups To Oversee NCI’s Translational Research.

June 22, 2007

ASCO Selects Three Cities For Quality Of Care Study.

June 2, 2000

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

Bladder Cancer Epidemiological Study Involves 3,000 Patients

March 2, 1979